FDA authorizes second booster dose of Moderna, Pfizer vaccines for older and immunocompromised individuals
WASHINGTON, D.C. — On Monday, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This […]